Dusseldorf - Delayed Quote EUR
Pacific Biosciences of California Inc (P09.DU)
0.9601
-0.0003
(-0.03%)
As of 4:00:11 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
154.01M
154.01M
200.52M
128.30M
130.51M
Cost of Revenue
116.73M
116.73M
147.74M
79.27M
71.65M
Gross Profit
37.28M
37.28M
52.78M
49.03M
58.86M
Operating Expense
327.94M
327.94M
363.14M
353.85M
237.02M
Operating Income
-290.66M
-290.66M
-310.37M
-304.82M
-178.16M
Net Non Operating Interest Income Expense
-13.41M
-13.41M
-14.34M
-14.69M
-12.53M
Other Income Expense
-5.46M
-5.46M
6.55M
5.26M
-84.18M
Pretax Income
-309.54M
-309.54M
-318.16M
-314.25M
-274.87M
Tax Provision
316.00k
316.00k
-11.42M
0.00
-93.65M
Net Income Common Stockholders
-309.85M
-309.85M
-306.74M
-314.25M
-181.22M
Diluted NI Available to Com Stockholders
-309.85M
-309.85M
-306.74M
-314.25M
-181.22M
Basic EPS
-1.13
-1.13
-1.21
-1.40
-0.89
Diluted EPS
-1.59
-1.59
-1.21
-1.40
-0.89
Basic Average Shares
274.49M
274.49M
253.63M
224.55M
204.14M
Diluted Average Shares
288.37M
288.37M
253.63M
224.55M
204.14M
Total Operating Income as Reported
-474.31M
-474.31M
-334.47M
-307.20M
-210.44M
Total Expenses
444.68M
444.68M
510.89M
433.12M
308.68M
Net Income from Continuing & Discontinued Operation
-309.85M
-309.85M
-306.74M
-314.25M
-181.22M
Normalized Income
-286.75M
-286.75M
-281.54M
-311.87M
-125.60M
Interest Expense
13.41M
13.41M
14.34M
14.69M
12.53M
Net Interest Income
-13.41M
-13.41M
-14.34M
-14.69M
-12.53M
EBIT
-296.12M
-296.12M
-303.82M
-299.56M
-262.34M
EBITDA
-242.77M
-242.77M
-277.28M
-282.24M
-250.76M
Reconciled Cost of Revenue
81.39M
81.39M
127.36M
61.95M
60.07M
Reconciled Depreciation
53.35M
53.35M
26.53M
17.32M
11.59M
Net Income from Continuing Operation Net Minority Interest
-309.85M
-309.85M
-306.74M
-314.25M
-181.22M
Total Unusual Items Excluding Goodwill
-29.24M
-29.24M
-26.14M
-2.38M
-84.27M
Total Unusual Items
-29.24M
-29.24M
-26.14M
-2.38M
-84.27M
Normalized EBITDA
-213.53M
-213.53M
-251.15M
-279.86M
-166.49M
Tax Rate for Calcs
0.21
0.21
0.04
0.00
0.34
Tax Effect of Unusual Items
-6.14M
-6.14M
-940.86k
-2.38k
-28.65M
12/31/2021 - 10/28/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade